Workflow
建银国际:药明合联(02268)中期业绩符预期 升目标价至72港元
WUXI XDCWUXI XDC(HK:02268) 智通财经网·2025-08-20 03:17

Core Viewpoint - Jianyin International has raised the revenue forecasts for WuXi AppTec (02268) for 2025 to 2027 by 1%, 2%, and 23% respectively, reaching RMB 5.9 billion, RMB 8.3 billion, and RMB 10.8 billion [1] Group 1: Revenue and Profit Forecasts - The adjusted profit forecast for 2025 has been increased by 3% to RMB 1.6 billion, while the forecasts for 2026 and 2027 remain largely unchanged [1] - The target price has been raised from HKD 67 to HKD 72, maintaining an "outperform" rating [1] Group 2: Recent Performance - WuXi AppTec's net profit for the first half of 2025 was RMB 746 million, representing a year-on-year increase of 52.7% [1] - Adjusted net profit, excluding share-based payment expenses, grew by 50% year-on-year to RMB 801 million, aligning with the forecast [1] Group 3: Margin and Orders - The mid-term gross margin was 36.1%, in line with the forecast of 36.3%, and improved from 32.1% in the same period of 2024 [1] - The backlog of unfulfilled orders increased by 58% year-on-year to USD 1.3 billion, with North America accounting for over half of the total and showing significant growth [1]